drugset / Trial / NCT03085680

Curcumin and Function in Older Adults

NCT03085680

RandomizedParallel-groupDouble-blindPrevention

Summary

This placebo-controlled RCT tests whether dietary supplementation with curcumin maintains or improves cognitive and physical function in older adults who are at high risk of functional decline due existing (mild) functional impairments and elevated biomarkers of inflammation and explore the association between functional changes and changes in biological indicators of active inflammation.

Timeline

Start
2017-08-11
Primary completion
2019-10-18
Completion
2019-10-18

Drugs

EvaluationDrugModalityDoseRoute
Subject Curcumin Small molecule 1000 mg Oral

Indications